193 results on '"Kamdar, Forum"'
Search Results
2. Singling out the Heart: Revolutionizing Heart Failure by Harnessing Translational Technologies
3. Disparities in Practice Patterns by Sex, Race, and Ethnicity in Patients Referred for Advanced Heart Failure Therapies
4. Outcomes of Patients Referred for Cardiac Rehabilitation after Left Ventricular Assist Device Implantation
5. Navigating Early Careers in Heart Failure in the Era of Novel Coronavirus Disease-2019
6. Viral expression of a SERCA2a-activating PLB mutant improves calcium cycling and synchronicity in dilated cardiomyopathic hiPSC-CMs
7. Rapidly Progressive Left Ventricular Assist Device Outflow Graft Thrombosis Associated With COVID-19 Infection
8. Validation of the Minnesota Pectoralis Risk Score to Predict Mortality in the HeartMate 3 Population
9. Neuromuscular Cardiomyopathies
10. Molecular Biology of the Normal and Failing Heart
11. 454 A Human 3D Model of Duchenne Muscular Dystrophy Cardiomyopathy to Investigate Calcium Regulation and Mitochondrial Dysfunction
12. Prevalence of Myocardial Fibrosis by Left Ventricular Assist Device Apical Core Biopsy and Correlation with Other Markers of Myocardial Recovery
13. Cardiac calcium regulation in human induced pluripotent stem cell cardiomyocytes: Implications for disease modeling and maturation
14. Overestimation of Renal Function Using Serum Creatinine in the Advanced Heart Failure Population: A Call for Alternative Measures
15. Cardiomyopathy in a Dish: Using Human Inducible Pluripotent Stem Cells to Model Inherited Cardiomyopathies
16. Surgical Mechanical Circulatory Support
17. Hemolysis, Pump Thrombus, and Neurologic Events in Continuous-Flow Left Ventricular Assist Device Recipients
18. Integrative effects of dystrophin loss on metabolic function of the mdx mouse
19. Contemporary Controversies in Digoxin Use in Systolic Heart Failure
20. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices
21. Dystrophic Cardiomyopathy and Patients With Muscular Dystrophies
22. Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy
23. Dystrophic Cardiomyopathy and the Need for Cardiovascular Care
24. Body Mass Index And Natriuretic Peptides Trends Before And After Left Ventricular Assist Device: Evidence That Gains In Body Mass Follow On Resolution Of Heart Failure
25. Lessons Learned From Experience With Over 100 Consecutive HeartMate II Left Ventricular Assist Devices
26. A Rare Case Report of Severe Cardiomyopathy Associated with Myotonic Dystrophy Type 2
27. Outcomes of Patients Referred for Cardiac Rehabilitation After Left Ventricular Assist Device Implantation.
28. N-terminal pro B-type natriuretic peptide predicts mortality in patients with left ventricular hypertrophy
29. Effects on pre- and posttransplant pulmonary hemodynamics in patients with continuous-flow left ventricular assist devices
30. Effects of Centrifugal, Axial, and Pulsatile Left Ventricular Assist Device Support on End-Organ Function in Heart Failure Patients
31. Effect of Acute Xanthine Oxidase Inhibition on Myocardial Energetics During Basal and Very High Cardiac Workstates
32. Low thromboembolic risk for patients with the Heartmate II left ventricular assist device
33. Improved Survival and Decreasing Incidence of Adverse Events With the HeartMate II Left Ventricular Assist Device as Bridge-to-Transplant Therapy
34. Experience with the Levitronix CentriMag circulatory support system as a bridge to decision in patients with refractory acute cardiogenic shock and multisystem organ failure
35. Surgical Mechanical Circulatory Support
36. Intramural coronary light-chain amyloidosis and left ventricular assist device implantation
37. Early Post-operative Pump Thrombosis In Heartmate 3 LVAD Recipients: A Case Series
38. Heart Failure Hospitalization Trends During the Early Phase of the COVID 19 Pandemic
39. Stem Cell–Derived Cardiomyocytes and Beta-Adrenergic Receptor Blockade in Duchenne Muscular Dystrophy Cardiomyopathy
40. rare case report of severe cardiomyopathy associated with myotonic dystrophy type 2.
41. Safety of discontinuation of anti-coagulation in patients with continuous-flow left ventricular assist devices
42. A rare nonvalvular left ventricular papillary fibroelastoma: A case report
43. Treatment of focal transplant vasculopathy with a bioresorbable coronary artery stent
44. Dystrophin-Deficient Cardiomyopathy
45. Abstract 18056: Modeling Duchenne Muscular Dystrophy (DMD) Cardiomyopathy Using Patient-specific Induced Pluripotent Stem Cell-derived Cardiomyocytes
46. Pulmonary Arterial Hypertension in von Recklinghausen's Disease
47. Percutaneous thoracic paravertebral block reduces refractory ventricular tachyarrhythmias after left ventricular assist device implantation
48. Late Effusive-constrictive Pericarditis after Lung Transplantation
49. MODELING DUCHENNE MUSCULAR DYSTROPHY (DMD) CARDIOMYOPATHY USING HUMAN INDUCED PLURIPOTENT STEM CELLS (HIPSC)
50. Abstract 19236: Effect of Continuous Flow Left Ventricular Assist Device on Diastolic Pulmonary Artery Pressure-to-Pulmonary Capillary Wedge Pressure Gradient in End Stage Heart Failure Patients with Pulmonary Hypertension
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.